Editorial: The evolution in pharmacology of infectious diseases: 2022

Exequiel O.J. Porta; Ali Saffaei; Karunakaran Kalesh

doi:10.3389/fphar.2024.1386077

Editorial: The evolution in pharmacology of infectious diseases: 2022

Exequiel O.J. Porta
, Ali Saffaei
, Karunakaran Kalesh

Teesside University

Research output: Contribution to journal › Editorial › peer-review

Abstract

This editorial offers an insightful examination and analysis of the significant advancements in the field of infectious diseases from 2022 to 2023, specifically focusing on how these developments have transformed our approaches to combating such diseases. At the heart of this exploration is an overview of 15 pivotal articles featured in our Research Topic. These articles, contributed by 120 distinguished experts worldwide, represent a critical blend of knowledge, combining a range of expert insights and discoveries.

Original language	English
Article number	1386077
Journal	Frontiers in Pharmacology
Volume	15
DOIs	https://doi.org/10.3389/fphar.2024.1386077
Publication status	Published - 12 Mar 2024

Access to Document

10.3389/fphar.2024.1386077

Cite this

@article{36538412fc3d4c2ba40cadd1c0ca87ed,

title = "Editorial: The evolution in pharmacology of infectious diseases: 2022",

abstract = "This editorial offers an insightful examination and analysis of the significant advancements in the field of infectious diseases from 2022 to 2023, specifically focusing on how these developments have transformed our approaches to combating such diseases. At the heart of this exploration is an overview of 15 pivotal articles featured in our Research Topic. These articles, contributed by 120 distinguished experts worldwide, represent a critical blend of knowledge, combining a range of expert insights and discoveries. ",

author = "Porta, \{Exequiel O.J.\} and Ali Saffaei and Karunakaran Kalesh",

year = "2024",

month = mar,

day = "12",

doi = "10.3389/fphar.2024.1386077",

language = "English",

volume = "15",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Editorial

T2 - The evolution in pharmacology of infectious diseases: 2022

AU - Porta, Exequiel O.J.

AU - Saffaei, Ali

AU - Kalesh, Karunakaran

PY - 2024/3/12

Y1 - 2024/3/12

N2 - This editorial offers an insightful examination and analysis of the significant advancements in the field of infectious diseases from 2022 to 2023, specifically focusing on how these developments have transformed our approaches to combating such diseases. At the heart of this exploration is an overview of 15 pivotal articles featured in our Research Topic. These articles, contributed by 120 distinguished experts worldwide, represent a critical blend of knowledge, combining a range of expert insights and discoveries.

AB - This editorial offers an insightful examination and analysis of the significant advancements in the field of infectious diseases from 2022 to 2023, specifically focusing on how these developments have transformed our approaches to combating such diseases. At the heart of this exploration is an overview of 15 pivotal articles featured in our Research Topic. These articles, contributed by 120 distinguished experts worldwide, represent a critical blend of knowledge, combining a range of expert insights and discoveries.

UR - https://www.scopus.com/pages/publications/85188618928

U2 - 10.3389/fphar.2024.1386077

DO - 10.3389/fphar.2024.1386077

M3 - Editorial

C2 - 38533259

AN - SCOPUS:85188618928

SN - 1663-9812

VL - 15

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1386077

ER -

Editorial: The evolution in pharmacology of infectious diseases: 2022

Abstract

Access to Document

Other files and links

Fingerprint

Cite this